{"schema_version":"secwatch.filing_event.v1","accession":"0001159036-26-000088","form_type":"8-K","ticker":"HALO","cik":"0001159036","company_name":"HALOZYME THERAPEUTICS, INC.","filed_at":"2026-07-02T20:10:08+00:00","discovered_at":"2026-07-02T20:11:00.532509+00:00","generated_at":"2026-07-02T20:11:08.791290+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Halozyme announces departure of COO Cortney Caudill","bullets":["Cortney Caudill departed as SVP, Chief Operating Officer on June 30, 2026.","No replacement has been named; company thanked Caudill for her contributions.","Departure is part of an update to senior management structure."],"urls":{"canonical":"https://secwatch.observer/filing/0001159036-26-000088","json":"https://secwatch.observer/filing/0001159036-26-000088.json","markdown":"https://secwatch.observer/filing/0001159036-26-000088.md","text":"https://secwatch.observer/filing/0001159036-26-000088.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000088/0001159036-26-000088-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1159036/000115903626000088/halo-20260630.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-02T20:11:08.791290+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}